Implementation Guide CH VACD
5.0.0 - trial-use Switzerland flag

This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example Immunization: TCC1 Immunization by patient

Generated Narrative: Immunization TCC01-IMMUN1-patient

Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp

Entry Resource Cross References

  • entry: Identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/acc1f090-5e0c-45ae-b283-521d57c3aa2f
  • container: Identifier: URI/urn:uuid:b505b90a-f241-41ca-859a-b55a6103e753
  • relationcode: replaces

identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/375532dc-7e74-40dd-8564-3261e8d26603

status: Completed

vaccineCode: Havrix 1440

patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

occurrence: 2021-06-02

recorded: 2021-06-15 00:00:00+0200

lotNumber: AHAVB946A

route: Intramuscular use

Performers

-Actor
*PractitionerRole

ProtocolApplieds

-TargetDiseaseDoseNumber[x]
*Viral hepatitis, type A (disorder)1